Similar articles

• [Recombinant human erythropoietin and chronic kidney failure: current situation and therapeutic implications].

  Romero González R, Torquet Escuder P. Romero González R, et al. Med Clin (Barc). 1990 Nov 17;95(17):656-9. Med Clin (Barc). 1990. PMID: 2089205 Spanish. No abstract available.
• Recombinant human erythropoietin (rHuEPO) in the treatment of anaemia of chronic renal failure.

  Desai JD, Shah BV. Desai JD, et al. J Assoc Physicians India. 1991 Jun;39(6):483-5. J Assoc Physicians India. 1991. PMID: 1938855 Review. No abstract available.
• Treatment of the anaemia of end-stage renal disease with recombinant human erythropoietin.

  Verbeelen D, Hauglustaine D, Sennesael J. Verbeelen D, et al. Neth J Med. 1988 Aug;33(1-2):60-7. Neth J Med. 1988. PMID: 3247012 No abstract available.
• [Recombinant human erythropoietin in the treatment of the anemia of multiple myeloma with kidney failure].

  Arenas Gracia M, Abad Gosálvez A, Colomina Avilés J, Pascual Pérez R, Ferriz Moreno P. Arenas Gracia M, et al. An Med Interna. 1995 Apr;12(4):187-8. An Med Interna. 1995. PMID: 7620064 Review. Spanish.
• Utilization of erythropoietin in the treatment of the anemia due to chronic renal failure.

  Drüeke T, Zins B, Naret C, Casadevall N, Goureau Y, Bererhi L, Peterlongo F, Castaigne JP, Zingraff J, Delons S, et al. Drüeke T, et al. Adv Nephrol Necker Hosp. 1989;18:187-206. Adv Nephrol Necker Hosp. 1989. PMID: 2493715 Review.